Co-Diagnostics Inc (NASDAQ:CODX)’s traded shares stood at 0.31 million during the last session, with the company’s beta value hitting 0.59. At the close of trading, the stock’s price was $0.28, to imply a decrease of -5.22% or -$0.01 in intraday trading. The CODX share’s 52-week high remains $2.23, putting it -696.43% down since that peak but still an impressive 17.86% since price per share fell to its 52-week low of $0.23.
Co-Diagnostics Inc (NASDAQ:CODX) trade information
After registering a -5.22% downside in the last session, Co-Diagnostics Inc (CODX) has traded red over the past five days. The 5-day price performance for the stock is -8.10%, and -19.94% over 30 days. With these gigs, the year-to-date price performance is -63.23%.
The extremes give us $6 and $6 for target low and target high price respectively. As such, CODX has been trading -2042.86% off suggested target high and -2042.86% from its likely low.
Co-Diagnostics Inc (CODX) estimates and forecasts
The rating firms project that company’s revenue will shrink -75.74% compared to the previous financial year.
Revenue forecast for the current quarter as set by 1 analysts is 300k. Meanwhile, for the current quarter, a total of 1 analyst(s) estimate revenue growth to 300k.Earnings reports from the last fiscal year show that sales brought in 2.66M and 641.14k respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to fall -88.71% before dropping -53.21% in the following quarter.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -27.40% for the past 5-year period. While 2025 is set for a 13.71% return in earnings, projections for the next 5 years are at 37.69% annually.
CODX Dividends
Co-Diagnostics Inc has its next earnings report out in July. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
The next major institution holding the largest number of shares is RENAISSANCE TECHNOLOGIES LLC with 0.59 million shares, or about 1.9486% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $0.73 million.
We also have VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Co-Diagnostics Inc (CODX) shares. Going by data provided on Mar 31, 2025 , VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund holds roughly 1.28 shares. This is just over 3.80% of the total shares, with a market valuation of $0.35 million. Data from the same date shows that the other fund manager holds a little less at 444.78, or 1.32% of the shares, all valued at about 0.12 million.
